Related references
Note: Only part of the references are listed.Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice
Elaheh Davarpanah et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis
Jianhui Zhang et al.
PLOS ONE (2020)
CD4+ T Cell-Mediated Immunity against the Phagosomal Pathogen Leishmania: Implications for Vaccination
Leah S. Hohman et al.
TRENDS IN PARASITOLOGY (2019)
Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View
Rafael Tiburcio et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis
Manas R. Dikhit et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Peptide Vaccines for Leishmaniasis
Rory C. F. De Brito et al.
FRONTIERS IN IMMUNOLOGY (2018)
Translating Observations From Leishmanization into Non-Living vaccines: The Potential of Dendritic Cell-Based vaccination Strategies Against Leishmania
Negar Seyed et al.
FRONTIERS IN IMMUNOLOGY (2018)
Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides
Maria Agallou et al.
MOLECULAR IMMUNOLOGY (2018)
Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice
Nahid Maspi et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.
Esther Moreno et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis
Evita Athanasiou et al.
FRONTIERS IN IMMUNOLOGY (2017)
A Chimera Containing CD4+and CD8+T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection
Marcus Vinicius Alves-Silva et al.
FRONTIERS IN IMMUNOLOGY (2017)
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
Nazia Khatoon et al.
SCIENTIFIC REPORTS (2017)
Peptide-based synthetic vaccines
Mariusz Skwarczynski et al.
CHEMICAL SCIENCE (2016)
Post-Genomics and Vaccine Improvement for Leishmania
Negar Seyed et al.
FRONTIERS IN MICROBIOLOGY (2016)
SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKCβ
Junaid Jibran Jawed et al.
PATHOGENS AND DISEASE (2016)
Leishmania infantum FML pulsed-dendritic cells induce a protective immune response in murine visceral leishmaniasis
Faeze Foroughi-Parvar et al.
IMMUNOTHERAPY (2015)
Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model
A. Katebi et al.
MOLECULAR IMMUNOLOGY (2015)
DNA is an efficient booster of dendritic cell-based vaccine
Jinyao Li et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE
Rhea N. Coler et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2015)
Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
Negar Seyed et al.
PLOS ONE (2014)
Modular Multiantigen T Cell Epitope-Enriched DNA Vaccine Against Human Leishmaniasis
Shantanabha Das et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Experimental validation of multi-epitope peptides including promising MHC class I- and II-restricted epitopes of four known Leishmania infantum proteins
Maria Agallou et al.
FRONTIERS IN IMMUNOLOGY (2014)
Antigen-pulsed CpG-ODN-activated dendrtic cells induce host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice: critical role of CXCL10
Saikat Majumder et al.
FRONTIERS IN IMMUNOLOGY (2014)
CD4+ T Cell Persistence and Function after Infection Are Maintained by Low-Level Peptide:MHC Class II Presentation
Ryan W. Nelson et al.
JOURNAL OF IMMUNOLOGY (2013)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity
Ines Matos et al.
PLOS ONE (2013)
Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
Noushin Saljoughian et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
T Cell-Derived IL-10 Determines Leishmaniasis Disease Outcome and Is Suppressed by a Dendritic Cell Based Vaccine
Tobias Schwarz et al.
PLOS PATHOGENS (2013)
Design of immunogenic and effective multi-epitope DNA vaccines for melanoma
Hyun-Il Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
CXCL10 Is Critical for the Generation of Protective CD8 T Cell Response Induced by Antigen Pulsed CpG-ODN Activated Dendritic Cells
Saikat Majumder et al.
PLOS ONE (2012)
Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis
Maria Agallou et al.
VACCINE (2012)
KSAC, the First Defined Polyprotein Vaccine Candidate for Visceral Leishmaniasis
Yasuyuki Goto et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection
Delaram Doroud et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis
Maria Agallou et al.
VACCINE (2011)
In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
Negar Seyed et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice
Wenhui Wu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Dendritic Cell Mediated Delivery of Plasmid DNA Encoding LAMP/HIV-1 Gag Fusion Immunogen Enhances T Cell Epitope Responses in HLA DR4 Transgenic Mice
Gregory G. Simon et al.
PLOS ONE (2010)
DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
Daejin Kim et al.
VACCINE (2010)
Immunogenicity and Efficacy of Single Antigen Gp63, Polytope and PolytopeHSP70 DNA Vaccines against Visceral Leishmaniasis in Experimental Mouse Model
Rakhee Sachdeva et al.
PLOS ONE (2009)
Mining the Leishmania genome for novel antigens and vaccine candidates
Carla Herrera-Najera et al.
PROTEOMICS (2009)
Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice
Salvador Iborra et al.
MICROBES AND INFECTION (2008)
Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice
Javier Carrion et al.
MICROBES AND INFECTION (2007)
Adjuvant activity of CpG oligodeoxynucleotides
Dennis M. Klinman
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2006)
IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection
CB Stober et al.
JOURNAL OF IMMUNOLOGY (2005)
The genome of the kinetoplastid parasite, Leishmania major
AC Ivens et al.
SCIENCE (2005)
Activation of dendritic cells: translating innate into adaptive immunity
CRE Sousa
CURRENT OPINION IN IMMUNOLOGY (2004)
Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis
P Tsagozis et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2004)
Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC
JR Ramírez-Pineda et al.
JOURNAL OF IMMUNOLOGY (2004)
The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development
P Scott et al.
IMMUNOLOGICAL REVIEWS (2004)
Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis
A Zadeh-Vakili et al.
VACCINE (2004)
Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells
S Herath et al.
PARASITE IMMUNOLOGY (2003)
CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major
Y Belkaid et al.
JOURNAL OF IMMUNOLOGY (2002)
A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major
S Rafati et al.
VACCINE (2001)
Share Paper
